- Advertisement -
A world-first study published in medical journal The Lancet this week found cervical cancer rates in the United Kingdom were 87 per cent lower in adult women who had received a recombinant human papillomavirus vaccine while they were 12 to 13-years-old.Medical pioneers Professor Ian Frazer and…
Click here to view the original article.
